Skip to content

Comparison of two methods with and without creasing of part of the stomach in patients with morbid obesity

Comparison of Roux-en-Y Gastric Bypass techniques with and without distal gastric plication in Patients with morbid obesity referring to the hospitals affiliated to the Jundishapur University of Medical Sciences, Ahvaz during 2019-2020

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201201049551N1
Enrollment
40
Registered
2020-12-08
Start date
2020-12-09
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid obesity. Body mass index (BMI) 40.0-44.9, adult.

Interventions

Intervention 1: Intervention group: Gastric bypass by distal plication method, in the Roux-en-Y method with distal gastric plication, the gastric puncture is about 25 ml and the biliopancreatic length

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age 18-65 years Obesity with a BMI of more than 35 with comorbidity disease or more than 40 kg / m2 Obesity with comorbidity diseases Patients with consent to participate in the study

Exclusion criteria

Exclusion criteria: Debilitating diseases, including cancer, tuberculosis, AIDS Having diseases that limit patient-physician communication, such as Alzheimer's Recorded history of mental illness (major depression or uncontrolled psychosis) Drug and alcohol abuse Severe heart disease with risk of anesthesia Severe coagulopathy Not accepting nutritional orders History of gastric surgery or antireflux surgery High-grade dysplasia in Barrett's esophagus Severe iron deficiency anemia Distal lesions of the stomach or duodenum require follow-up Patients with no consent to participate in the study

Design outcomes

Primary

MeasureTime frame
Weight Loss. Timepoint: Two weeks, 1,2,6, 12 months after surgery. Method of measurement: The rate of weight loss two weeks after surgery is 4%, 1 month after 8%, 3 months after 18%, 6 months after 30%, 12 months after 40% relative to baseline weight.

Secondary

MeasureTime frame
The amount of ghrelin hormone. Timepoint: Six, 12 months after surgery. Method of measurement: Pg/mL.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Askari M.D

Ahvaz University of Medical Sciences

askari-m@ajums.ac.ir+98 61 3374 3001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026